Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years

Treatment for patients > 60 years with classical Hodgkin lymphoma (cHL) is problematic; there is no gold standard, and outcome is poor. Using the Swedish Lymphoma Registry, we analysed all Swedish patients diagnosed with cHL between 2000 and 2014 (N = 2345; median age 42 years; 691 patients were ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahlin, Björn Engelbrekt, Övergaard, Ninja, Peterson, Stefan, Digkas, Evangelos, Glimelius, Ingrid, Lagerlöf, Ingemar, Johansson, Ann‐Sofie, Palma, Marzia, Hansson, Lotta, Linderoth, Johan, Goldkuhl, Christina, Molin, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175745/
https://www.ncbi.nlm.nih.gov/pubmed/35844675
http://dx.doi.org/10.1002/jha2.202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175745/
https://www.ncbi.nlm.nih.gov/pubmed/35844675
http://dx.doi.org/10.1002/jha2.202

Ejemplares similares